Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melphalan and hyperthermia in malignant melanoma
NCT00002973Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Dec 1995
- Primary completion
- May 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melphalan in melanoma, sponsored by University of Wisconsin–Madison. Started Dec 1995; status: completed.
02
Drugs
melphalan
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00002973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002973.